Upcoming Medical Conferences in Bethesda

MedStar Genomic Medicine: Pharmacogenomics 2019 is organized by MedStar Health and will be held on Mar 23, 2019 at Bethesda Marriott, Bethesda, Maryland, United States of America. The target audience for this medical event is primary care providers, family practitioners, oncologists, psychiatrists, cardiologists, physician assistants, nurse practitioners, pharmacists and all other members of the healthcare team interested in pharmacogenomics. This Conference has been approved for a maximum of 9 Interprofessional Continuing Education (IPCE) credits for learning and change. Conference Description: The program aims to provide an overview of genomic medicine and pharmacogenetics, review specialties where advancements in pharmacogenetics can improve the quality of care, and offer perspective from leading experts in how pharmacogenetics can transform clinical practice. Despite patient and clinician interest in genomic medicine, education is often the limiting factor to clinical application. The program will include general concepts necessary for foundational knowledge in genomic medicine. Attendees will be exposed to a variety of use cases for pharmacogenetics (e.g., pain management, psychiatry, cardiology) and molecular tumor profiling in oncology. Case-based discussions will allow practitioners and healthcare professionals to hear and discuss real-world experiences in using pharmacogenetics in the daily practice of medicine. Conference Objectives: • Summarize foundational concepts related to genomic medicine and pharmacogenetics • Identify key resources for the clinical application of pharmacogenetics • Recognize that evidence levels vary between different drug-gene pairs • Identify clinical scenarios where a genetic result can guide therapy • Explain how pharmacogenetic results can be used in prescribing decisions Additional details will be posted as soon as they are available.

Kidney and Bladder Cancers: Updates on Clinical Management 2019 is organized by MedStar Health and will be held on Mar 23, 2019 at Bethesda North Marriott Hotel & Conference Center, Bethesda, Maryland, United States of America. The target audience for this medical event is oncologists, pathologists, radiation oncologists, urologists, residents, fellows, medical students, nurse practitioners, nurses, physician assistants, pharmacists, allied health professionals, and other members of the healthcare team interested in the management of kidney and bladder cancers. This Conference has been approved for a maximum of 7.25 Interprofessional Continuing Education (IPCE) Credits. Conference Description: This biennial, multidisciplinary, one-day conference will provide an update on the clinical management of patients with kidney and bladder (urothelial) cancers. Didactic lectures will present the many recent advances in the treatment of these diseases and their integration into the multidisciplinary management of patients with early stage, high risk, and metastatic disease. Presentations will also discuss emerging controversies and ongoing research aimed at addressing them. Interactive discussions with experts in the field will enhance the learning experience. Conference Objectives: • Discuss current status of adjuvant therapy for patients with high risk kidney cancer. • Analyze treatment options for second line therapy for immune therapy resistant kidney cancer. • Evaluate the role of immune therapy alone and in combination for patients with kidney cancer. • Discuss the current approaches to treatment of patients with non clear cell kidney cancer. • Evaluate the changing role of VEGF therapy in patients with kidney cancer. • Analyze current unresolved clinical management issues and clinical research opportunities. • Evaluate the role of surgery in the management of patients with all stages of kidney cancer • Describe the evaluation and management of BCG refractory non-muscle invasive bladder cancer. • Evaluate molecular advances in urothelial carcinoma that support personalized bladder cancer management strategies. • Describe the evolution of immunotherapy in the treatment of advanced urothelial cancer. • Utilize appropriate multidisciplinary therapy approaches for muscle invasive bladder cancer. • Analyze critical clinical questions in urothelial carcinoma that are being addressed by clinical research. • Recognize drug therapies used in the treatment of clear cell RCC and non clear cell RCC. • Explain the role of cytoreductive nephrectomy in the treatment of RCC. • Recognize toxicities and optimize the management of class-specific side effects of renal cell carcinoma therapies including immunotherapy and VEGFR TKIs. • Utilize multidisciplinary evaluation and assessment to contribute to more effective and expedited patient treatment. • Recognize toxicities and optimize the management of class-specific side effects of bladder cancer therapies. • Analyze the current available treatment approaches including systemic and novel treatments, in non-muscle invasive bladder cancer. • Discuss the role of immunotherapy in the treatment of bladder and kidney cancers. • Identify common immune related adverse effects and their management based on current guidelines and evidence.

Robert J. Wenthold Memorial Lecture. Sounds in Silence: How the Cochlea Promotes Refinement of Auditory Circuits before Hearing Onset is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Apr 29, 2019 at John Edward Porter Neuroscience Research Center, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on May 17, 2019 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

North American Primary Care Research Group (NAPCRG) Practice-based Research Network (PBRN) Conference is organized by North American Primary Care Research Group (NAPCRG) and would be held during Jun 24 - 25, 2019 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

EARssentials: Concepts and Techniques of Contemporary Hearing Research 2019 is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held from Jul 15 - 19, 2019 at National Institutes of Health, Bethesda, Maryland, United States of America. This free, week-long course, hosted and taught by scientists at the National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health (NIH), provides students with an overall conceptual view of the auditory system as well as hands-on exposure to laboratory techniques unique to research on the inner ear. The primary audience for this course is new intramural NIDCD trainees, including post-doctoral, graduate, post-baccalaureate, and summer students. Scientists from other institutions are welcome to attend as well. The course is also useful for others who want to learn about concepts related to the auditory system. The class is divided into two segments: •  Lecture sessions in the mornings, in which scientists introduce and discuss a wide array of concepts related to the auditory system. •  Hands-on laboratory sessions in the afternoon. Each session will feature a different technique commonly used in hearing and balance research.  Topics: inner ear development and morphology, genetics of hearing loss, auditory and vestibular function, stereocilia structure, mechanotransduction, inner ear innervation, cell death, hair cell regeneration, and the zebrafish lateral line Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Sep 13, 2019 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

2019 Adult Congenital Heart Disease (ACHD) Conference is organized by MedStar Health and will be held from Oct 04 - 05, 2019 at Bethesda Marriott, Bethesda, Maryland, United States of America.  Target Audience Anesthesiology, Cardiac Electrophysiology, Cardiac Surgery, Cardiovascular Disease, Obstetrics, Pediatrics. Credits:  AMA PRA Category 1™ Physician (12.50), Nurse - ANCC (12.50), Non-Physician Member of the Healthcare Team (12.50), IPCE (12.50) Course Description: Due to advances in medical and surgical therapies for patients with congenital heart disease (CHD), children and adolescents with CHD have over a 90% survival rate. As a result, the number of adults with CHD in the United States has now surpassed the number of children with these conditions. This two-day program offers physicians and other health care providers a comprehensive review of the evaluation, diagnosis and management of adult congenital heart disease, including the management of heart disease during pregnancy. Through a series of multidisciplinary lectures and question and answer sessions the ACHD conference invites all disciplines to examine the progression and treatment of congenital heart disease from adolescence through adulthood. Track 1 will be an interactive multidisciplinary session integrating expertise from cardiologists, anesthesiologists, and maternal fetal medicine specialists on the care of the pregnant patient with cardiac disease. Women with CHD are 8 times as likely to experience cardiovascular complications during pregnancy and have a 6 times higher risk of dying than women without CHD. Managing these patients through pregnancy safely can be challenging and requires a multidisciplinary approach. This track will be case based, with an opportunity for discussion and interaction with the experts. Track 2 will be an interactive session that focuses on specific cardiac defects by providing an integrated anatomy review with 3D heart models, imaging review with a focus on echocardiogram and MRI, and key clinical management review. The session will include audience response questions and an opportunity to review 3D heart models with experts in cardiac pathology.  Course Objectives: At the conclusion of this activity, the learner will be able to: • Identify the increasing prevalence of adults with congenital heart disease and address some of the complications that can result from lifelong congenital heart disease. • Consult and coordinate with expert maternal-fetal medicine care for optimization of outcomes for mothers and babies. • Review current and innovative imaging techniques for simple and complex congenital heart lesion. • Review new and innovative PAH therapies that might be utilized for patients with adult congenital heart disease • Review new and innovative advanced mechanical support therapies that might be utilized for patients with adult congenital heart disease • Consult and coordinate with ACHD and PH experts for the care of ACHD patients with PAH and single ventricle heart disease • Consult and coordinate with ACHD experts for cardiac transplantation and advanced mechanical support evaluation in ACHD patients • Recognize the importance of consulting ACHD specialists in the evaluation and care of pregnant ACHD patients • Appraise the catheter-based interventional procedures in adults with congenital heart disease. • Appraise the indications of pacemaker and defibrillator therapy in adults with congenital heart disease. • Identify the increasing prevalence of adults with congenital heart disease and address some of the complications that can result from lifelong congenital heart disease. • Consult and coordinate with expert maternal/fetal medicine care for optimization of outcomes for mothers and babies and determining appropriate contraceptive options. • Identify underlying cardiac anatomy and structural repairs in congenital heart disease Additional details will be posted as soon as they are available. 

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Jan 31, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on May 29, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.